Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 06, 2024 07:30 ET
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
ADC Therapeutics SA (NYSE: ADCT) today announced that it has agreed to sell, by way of an underwritten offering, 13,411,912 of its common shares at a price of $4.900 per share and, to certain investors who so choose in lieu of common shares,...
May 06, 2024 07:30 ET
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced that Maria Maccecchini, Founder, President, and CEO of Annovis, issued a letter...
May 06, 2024 07:30 ET
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced that it has hired a deposit-focused Group that will cover the Williamsburg market. The Group will be led by...
May 06, 2024 07:30 ET
ETFS Capital Files Definitive Proxy Statement and Releases Letter to Fellow WisdomTree Stockholders
ETFS Capital Limited (“ETFS Capital”), the largest combined owner of common stock, $0.01 par value (the “Common Stock”), and Series A Non-Voting Convertible Preferred Stock (the “Series A Preferred Stock”) of WisdomTree, Inc. (“WisdomTree” or the...
May 06, 2024 07:30 ET
Metasphere Labs Announces a Follow-Up Event Regarding Bitcoin’s Defi Revolution
Metasphere Labs Inc. ("Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is delighted to announce a follow-up event tailored for those who were unable to attend the initial sessions, in response to the overwhelming demand...
May 06, 2024 07:30 ET
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related...
May 06, 2024 07:30 ET
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that it has entered...
May 06, 2024 07:30 ET
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024....
May 06, 2024 07:30 ET
Spectral Medical Provides April Tigris Trial Update
Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating...
May 06, 2024 07:30 ET
Tyson Foods Reports Second Quarter 2024 Results
Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, reported the following...
May 06, 2024 07:22 ET
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer
Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive...
May 06, 2024 07:15 ET
Flow Capital Announces Repayment of USD 4.5 Million Investment
Flow Capital Corp. (TSXV: FW) ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to...
May 06, 2024 07:15 ET
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1...
May 06, 2024 07:13 ET
N2OFF: Save Foods to Target California’s Hemp Market
N2OFF, Inc.\ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to...
May 06, 2024 07:12 ET
Skyward Specialty Announces Secondary Offering of Its Common Stock
Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”) market, announced that The Westaim Corporation (“Westaim”), through its wholly-owned subsidiary,...
May 06, 2024 07:03 ET
Flash News: OKX Launches Cryptopedia Season 17 Campaign Featuring 6,666,666 Ultiverse Token Prize Pool
OKX, a leading Web3 technology company, has issued updates for May 6, 2024. OKX Launches Cryptopedia Season 17 Campaign Featuring 6,666,666 Ultiverse Token Prize Pool OKX today announced the launch of Season 17 of Cryptopedia, a learn-to-earn...
May 06, 2024 07:01 ET
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in...
May 06, 2024 07:00 ET
BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the company will participate in the RBC Capital...
May 06, 2024 07:00 ET
AMG Reports Financial and Operating Results for the First Quarter of 2024
AMG, a leading partner to independent investment management firms globally, today reported its financial and operating results for the first quarter of 2024. Jay C. Horgen, President and Chief Executive Officer of AMG, said:“In the first quarter,...
May 06, 2024 07:00 ET
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced financial results for the first quarter ended March 31,...